Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 2
2001 4
2002 4
2003 7
2004 8
2005 9
2006 11
2007 18
2008 14
2009 13
2010 32
2011 27
2012 20
2013 14
2014 25
2015 28
2016 43
2017 36
2018 35
2019 41
2020 52
2021 59
2022 69
2023 70
2024 40

Text availability

Article attribute

Article type

Publication date

Search Results

595 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer.
Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, Zhang Y, Zhao W, Zhou F, Li W, Zhang J, Zhang X, Qiao M, Gao G, Chen S, Chen X, Li X, Hou L, Wu C, Su C, Ren S, Odenthal M, Buettner R, Fang N, Zhou C. Wu F, et al. Among authors: xiong a. Nat Commun. 2021 May 5;12(1):2540. doi: 10.1038/s41467-021-22801-0. Nat Commun. 2021. PMID: 33953163 Free PMC article.
Advances in AP2/ERF super-family transcription factors in plant.
Feng K, Hou XL, Xing GM, Liu JX, Duan AQ, Xu ZS, Li MY, Zhuang J, Xiong AS. Feng K, et al. Among authors: xiong as. Crit Rev Biotechnol. 2020 Sep;40(6):750-776. doi: 10.1080/07388551.2020.1768509. Epub 2020 Jun 10. Crit Rev Biotechnol. 2020. PMID: 32522044 Review.
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody.
Song X, Xiong A, Wu F, Li X, Wang J, Jiang T, Chen P, Zhang X, Zhao Z, Liu H, Cheng L, Zhao C, Wang Z, Pan C, Cui X, Xu T, Luo H, Zhou C. Song X, et al. Among authors: xiong a. J Immunother Cancer. 2023 Feb;11(2):e006234. doi: 10.1136/jitc-2022-006234. J Immunother Cancer. 2023. PMID: 36854570 Free PMC article. Clinical Trial.
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.
Zhu X, Sun L, Song N, He W, Xie B, Hu J, Zhang J, Yang J, Dai J, Bian D, Xia H, Sun F, Xiong A, Luo J, Zhang L, Yu H, Liu M, Liu H, Wang H, Zhang H, Chen C, Wu C, Duan L, Zhu Y, Zhang P, Jiang G. Zhu X, et al. Among authors: xiong a. BMC Med. 2022 Dec 30;20(1):493. doi: 10.1186/s12916-022-02696-4. BMC Med. 2022. PMID: 36581917 Free PMC article. Clinical Trial.
New insights into the role of long non-coding RNAs in osteoporosis.
Zhang W, Liu Y, Luo Y, Shu X, Pu C, Zhang B, Feng P, Xiong A, Kong Q. Zhang W, et al. Among authors: xiong a. Eur J Pharmacol. 2023 Jul 5;950:175753. doi: 10.1016/j.ejphar.2023.175753. Epub 2023 Apr 28. Eur J Pharmacol. 2023. PMID: 37119958 Review.
595 results